CAGR of 5.9% U.S. Degenerative Disc Disease Treatment Market 2021, Industry Analysis till 2028 | AnGes Inc., Ankasa Regenerative Therapeutics, Inc., BIOPHARM GMBH, BioRestorative Therapies Inc.

U.S. Degenerative Disc Disease Treatment Market is witnessing headwinds as the caseload for lower back pain rises

Overview

There are several types of treatment for degenerative disc disease. Nonsurgical approaches include physical therapy or a spinal injection. Homeopathic remedies may reduce the patient’s pain in the meantime. Surgical procedures such as lumbar fusion or spinal fusion may be necessary if the patient’s pain is severe. Surgery is often recommended for people suffering from degenerative disc disease. This type of treatment helps reduce the pressure on the spine by strengthening the muscles that support it. This will help relieve your pain both in the immediate term and in the long run. Patients who choose this treatment can expect to recover quicker and with less pain than those who opt for nonsurgical treatments.

Get FREE Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4590

Competitive Landscape

Major companies contributing to the U.S. degenerative disc disease treatment market include Geistlich Pharma AG, Eli Lilly and Company, FibroGenesis, Isto Biologics, Biosplice Therapeutics, Inc., CO.DON, Pfizer, Inc., Cerapedics, Inc., Notogen Inc., R3 Stem Cell, NC Biomatrix BV, Kunovus, DiscGenics Inc., Kolon TissueGene Inc., Creative Medical Technology Holdings, Inc., Mesoblast, Lineage Cell Therapeutics, Inc., Bone Therapeutics SA, Johnson & Johnson, Intralink-Spine, Inc., Ferring Pharmaceuticals, and Harbor View Medical Services.

Drivers

Increasing incidences of lower back and neck pain in the adult population are expected to foster growth in the U.S. degenerative disc disease treatment market throughout the forecast period.

In addition to this, an increasing number of chiropractic procedures in combination with the intake of NSAIDS (non-steroidal anti-inflammatory drugs) is expected to boost the growth of the U.S. degenerative disc disease treatment market over the forecast period.

𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐨 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐭𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏

Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/4590

The Epitome of the COVID-19 Debacle

The U.S. degenerative disc disease treatment market experienced a steep fall in demand due to the prevalence of the COVID-19 pandemic. The crisis-driven social distancing measures instigated the patients as well as the surgeons to switch to virtual consultations in lieu of in-person meetings at ambulatory care centers. On the brighter side, the market is performing well at current levels considering the progressive vaccination drives.

Key Takeaways

• The S. degenerative disc disease treatment market is anticipated to grow at a CAGR of 5.9 % during the forecast period owing to increasing research and development activities and an expanding biotechnology sector. For instance, in November 2021, the U.S. Food and Drug Administration (FDA) approved Theradaptive’s Osteo-Adapt SP Spinal Fusion to treat spondylolisthesis and degenerative disc disease in the U.S.
• On a related note, the growing trend of regenerative implants across the healthcare sector amidst a rising number of clinical trials is creating new growth avenues for the S. degenerative disc disease treatment market.

Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4590

Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snapshot, By Treatment
     • Market Snapshot, By Disease Indication
     • Market Snapshot, By Distribution Channel
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Opportunity
   • Impact Analysis
   • Pipeline Analysis
   • Regulatory Scenario
   • PEST Analysis
   • Patient Journey
   • Epidemiology
   • Patient Funnel
   • Patient Treatment Journey and Patient Share, By Treatment Type
   • Patient Share By Product Type In Overall Diagnosed Population
   • DDD Patient Numbers, By Pfirrmann Grade
   • Product Launch/Approvals
   • Acquisition, Collaboration & Agreements
   • Key Developments
   • Therapeutic Landscape
   • Future Therapeutic Landscape
4. U.S. Degenerative Disc Disease Treatment Market  – Impact of Coronavirus (COVID-19) Pandemic
   • Impact of Covid-19 on Supply and Demand of Degenerative Disc Disease Drugs
   • Impact on R&D activities of Degenerative Disc Disease therapeutics
5.  U.S. Degenerative Disc Disease Treatment Market, By Treatment Type, 2017 – 2028, Million (Number of Patient)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018– 2028
     • Segment Trends
   • Epidural Steroid Injections
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, Million (Number of Patient)
   •  Narcotics
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, Million (Number of Patient)
       • Morphine
       • Methadone Hydrochloride
       • Codeine
       • Hydrocodone
       • Tramodol
       • Oxycodone
       • Others
   • Orthobiologics (Includes Biomolecular/Gene Therapy, Cell-based Therapy, and Tissue-engineered Products)
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, Million (Number of Patient)
       • Phase I
       • Phase II
       • Phase III
6. U.S. Degenerative Disc Disease Treatment Market, By Disease Indication, 2017 – 2028, Million (Number of Patient)
   • Overview
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Early Stage
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, Million (Number of Patient)
   • Mid Stage
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, Million (Number of Patient)
   • Late Stage
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, Million (Number of Patient)
7. U.S. Degenerative Disc Disease Treatment Market, By Distribution Channel, 2017 – 2028, Million (Number of Patient)
   • Overview
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Hospital Pharmacies
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, Million (Number of Patient)
   • Retail Pharmacies
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, Million (Number of Patient)
   • Online Pharmacies
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, Million (Number of Patient)

View Press Release

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact US:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837